Gartner Earnings Surpass Estimates in Q2, Revenues Increase Y/Y

Gartner (IT) reported robust Q2 2025 results, with adjusted EPS of $3.53 surpassing estimates by 4.4% and increasing 9.6% year-over-year, alongside revenues of $1.7 billion, up 5.7% year-over-year and slightly beating consensus. Despite this strong quarterly performance, the company issued a mixed 2025 outlook, lowering its full-year revenue guidance to at least $6.46 billion and adjusted EBITDA guidance to at least $1.52 billion, while slightly raising its EPS outlook to at least $11.75; notably, all revised guidance figures remain below current Zacks Consensus Estimates. This cautious forward guidance contrasts with the strong quarter and comes as Gartner's stock has significantly underperformed, declining 30.5% year-to-date.

Analysis

Gartner, Inc. (IT) reported a dichotomous second quarter for 2025, delivering strong backward-looking results while issuing a cautious forward outlook. The company surpassed consensus estimates with a 9.6% year-over-year increase in adjusted EPS to $3.53 and a 5.7% rise in revenue to $1.7 billion, demonstrating growth across all three of its operating segments. However, this performance is overshadowed by a downward revision of its full-year 2025 guidance. Management lowered its revenue forecast to at least $6.46 billion and its adjusted EBITDA outlook to $1.52 billion, both of which are below prior guidance and current analyst consensus. While the adjusted EPS guidance was nominally increased to at least $11.75, it also remains significantly below the Zacks Consensus Estimate of $12.65. This muted outlook provides context for the stock's severe year-to-date underperformance, a decline of 30.5% which is more than double the fall of its industry peer group. The balance sheet shows a solid cash position of $2.2 billion, though the quarter also saw a free cash flow utilization of $347 million, contrasting with a maintained full-year FCF guidance of at least $1.15 billion.

Key Decisions for Investors

• Investors should prioritize the lowered full-year 2025 guidance for revenue and EBITDA over the Q2 earnings beat, as the forward-looking indicators suggest decelerating growth and fall short of consensus expectations.
• Given the stock's significant 30.5% year-to-date underperformance, the cautious guidance may confirm the market's existing concerns, warranting scrutiny over whether the negative outlook is fully priced in.
• Monitor the company's ability to meet its revised, lower guidance in subsequent quarters and pay close attention to free cash flow generation to ensure it tracks toward the maintained full-year target of $1.15 billion.